Clinical Trials Browser

Diffuse Intrinsic Pontine Glioma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma, Rhabdoid Tumor

Clinical Trials

Clinical and P

Evaluating Cancer Response to Treatment With Abemaciclib and Fulvestrant in Women With Recurrent Endometrial Cancer

LY3214996 Plus Abemaciclib in Recurrent Glioblastoma Patients

Abemaciclib Plus Darolutamide in Prostate Cancer That Has Spread After Initial Treatment

A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma

Abemaciclib and Niraparib Before Surgery for the Treatment of Hormone Receptor Positive HER2 Negative Breast Cancer

ABIGAIL

MORPHEUS HR+BC

Abemaciclib and Letrozole in Treating Patients With Endometrial Cancer

Abemacare

ABEMA Alone or in COMBO With MK-6482

Impact of Endocrine Therapy and Abemaciclib on Host and Tumor Immune Cell Repertoire/Function in Advanced ER+/HER2- Breast Cancer

This Study in Patients With Different Types of Cancer (Solid Tumours) Aims to Find a Safe Dose of Xentuzumab in Combination With Abemaciclib With or Without Hormonal Therapies. The Study Also Tests How Effective These Medicines Are in Patients With Lung and Breast Cancer

Abemaciclib in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer

First-in-Human Study of RLY-5836 in Advanced Breast Cancer and Other Solid Tumors

MyDRUG

ELAINEII

monarcHER

PACT

A Phase 1 Study of LY2835219 In Participants With Advanced Cancer

CYCLONE 1

ETIC

A Study of Abemaciclib (LY2835219) With and Without Food in Participants With Metastatic Breast Cancer

MiMe-A

A Study of Abemaciclib in Indian Women With Advanced Breast Cancer

AflacST1501

Study of LY2835219 for Mantle Cell Lymphoma

ATLANT

ABORL

A Study of ZN-c5 and Abemaciclib in Participants With Breast Cancer

A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer

A Study of Abemaciclib in Participants With Cancer That is Advanced or Has Spread to Another Part(s) of the Body

A Study of LY3023414 in Participants With Advanced Cancer

Korean Cancer Study Group: Translational bIomarker Driven UMbrella Project for Head and Neck (TRIUMPH), Esophageal Squamous Cell Carcinoma- Part 1 (HNSCC)]

Description of Treatment Patterns and Description and Comparison of Healthcare Resource Utilization and Costs of Women With Metastatic HR+/HER2- Breast Cancer Treated With CDK4/6 Inhibitors

A Real-world Analysis of Concomitant Medication Use Among Metastatic Breast Cancer Patients Treated With CDK4/6 Inhibitors

A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Therapies in Japanese Participants With Advanced Cancer

A Study of Abemaciclib (LY2835219) in Participants With Stage IV Squamous Non-small Cell Lung Cancer

A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer, Non-small Cell Lung Cancer, or Melanoma That Has Spread to the Brain

A Study of Abemaciclib (LY2835219) in Native Chinese Participants With Advanced and/or Metastatic Cancers

A Study of Abemaciclib (LY2835219) in Combination With Another Anti-cancer Drug in Participants With Lung Cancer (NSCLC)

A Study of LY2835219 in Japanese Participants With Advanced Cancer

A Study of Necitumumab and Abemaciclib in Participants With Non-Small Cell Lung Cancer (NSCLC)

neoMONARCH

MONARCH 1

A Study of Abemaciclib (LY2835219) Alone or in Combination With Other Agents in Participants With Previously Treated Pancreatic Ductal Adenocarcinoma

A Study in Advanced Cancers Using Ramucirumab (LY3009806) and Other Targeted Agents

A Study of LY2835219 in Participants With Cancer

ABC-POP